Page last updated: 2024-10-27

foscarnet and Acidosis, Renal Tubular, Type I

foscarnet has been researched along with Acidosis, Renal Tubular, Type I in 2 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Navarro, JF2
Quereda, C4
Gallego, N1
Antela, A1
Mora, C1
Ortuno, J1
Moreno, A1

Reviews

1 review available for foscarnet and Acidosis, Renal Tubular, Type I

ArticleYear
Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1996, Volume: 27, Issue:3

    Topics: Acidosis, Renal Tubular; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalov

1996

Other Studies

1 other study available for foscarnet and Acidosis, Renal Tubular, Type I

ArticleYear
Renal tubular acidosis following treatment with foscarnet.
    AIDS (London, England), 1995, Volume: 9, Issue:12

    Topics: Acidosis, Renal Tubular; Adult; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; HIV Seroposi

1995